ArticleTransplantation and cellular therapy2023

Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Janny M Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.